Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 “EVOGUARD” Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy
. To find out more, read our
Privacy Policy
and our
Cookie Policy.